Tag: Covid 19 Vaccine

Mandaviya said that over 65 percent of vaccines supplied in the world are from India.

As per the Odisha Health & Family Welfare department, the vaccination drive will be undertaken for those who have not received their second or precaution dose.

Corbevax is an indigenously developed peptide-based vaccine that is different from the viral vector (Covishield) or the inactivated vaccine (Covaxin).

Mandaviya said this while responding to queries of some Opposition MPs after his suo moto statement in Rajya Sabha on the latest COVID-19 situation and India's preparedness.

Eligible populations are the persons who have completed 6 months from the date of administration of the 2nd dose.

The Drugs Controller General of India (DCGI) on June 4 approved Corbevax as a precaution dose for those aged 18 and above.

The teacher in dock Madhav Roul allegedly beat up five students of Nuagada primary school moments after they returned from toilet.

Despite the incredible speed of the vaccine roll-out worldwide, more than 3.5 million Covid deaths have been reported

According to Maria van Kerkhove from the WHO's Health Emergencies Program, BA.4 and BA.5 have been detected in a number of countries. The WHO is still evaluating the severity of the two new variants.

Hyderabad-based vaccine manufacturer Bharat Biotech on Friday announced the temporary slowing down of its Covid vaccine Covaxin's production across its manufacturing facilities.

During the recent Omicron surge, those who were boosted were 21 times less likely to die from Covid-19 compared to those who were unvaccinated, and 7 times less likely to be hospitalised, according to the CDC.

Modi asserted that India's vaccination drive, which is the largest in the world, is science-driven.

"This failure is the direct result of policy and budgetary decisions that prioritize the health of people in wealthy countries over the health of people in poor countries," said the secretary-general.

Meanwhile, the weekly positivity rate has come down to 0.99 per cent while daily positivity rate stands at 0.74 per cent.

The US has already approved the fourth dose for immunocompromised people, such as those living with HIV or certain transplant recipients. Other countries that have approved the fourth shot include the UK, Chile.